acute myeloid leukemia

(redirected from acute myelogenous leukemia)
Also found in: Dictionary, Medical, Financial, Acronyms, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for acute myeloid leukemia

acute leukemia characterized by proliferation of granular leukocytes

References in periodicals archive ?
Although cases with spontaneous regression of ALC and others with acute myelogenous leukemia (AML) have been reported, this condition is extremely rare (13-14).
The IOM's subsequent review of the evidence found there is "inadequate or insufficient evidence" to establish a connection between the parent's Agent Orange exposure and development of acute myelogenous leukemia.
The Company also has a cancer stem cell (CSC) antibody discovery program focused on therapies for acute myelogenous leukemia, multiple myeloma and myelodysplastic syndrome.
The contract has been signed to accelerate development of a targeted immunotherapy for patients with acute myelogenous leukemia.
William ``Pete'' Knight, R-Palmdale, is hospitalized with acute myelogenous leukemia and will be undergoing treatment, a spokesman said Tuesday.
Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal stem cell disorders that give rise to progressive cytopenias (decreases in white cells, red cells and platelets), which can evolve into acute myelogenous leukemia (AML).
VA said the researchers noted errors in the study, and, after correcting their data, announced that children of Australia's Vietnam vets were not at a greater risk of developing acute myelogenous leukemia (AML).
The drive is the brainchild of GM's vice chairman Harry Pearce who successfully underwent an allogeneic bone marrow transplant for the treatment of acute myelogenous leukemia.
of the Memorial Sloan-Kettering Cancer Center in New York and his colleagues have given a low-dose arsenic treatment to 10 people suffering from a white blood cell cancer known as acute myelogenous leukemia.
com) announces updates to their Acute Myelogenous Leukemia research database.
M2 EQUITYBITES-May 19, 2015-Agios passes US FDA's fast track designation for AG-120 for treating acute myelogenous leukemia
Friday's event was the 10th reunion for Pasadena resident Richard Myers, who had a transplant in 1994 in his battle against acute myelogenous leukemia.
With optimal standard chemotherapy, 70% of acute myelogenous leukemia (AML) patients enter remission; however, only 20% live to become long-term survivors, and the average time of AML-patient survival is merely 18 months.
Full browser ?